This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Bristol-Myers Squibb Compnay, Janssen Pharmaceutica Nv. Active years: 2025.
Company Filing History:
1 out of 3,737 
1 out of 2,100 
Years Active: 2025
Title: Subha Mukherjee: Innovator in Pharmaceutical Synthesis
Introduction
Subha Mukherjee is a notable inventor based in Princeton, NJ, who has made significant contributions to the field of pharmaceutical synthesis. His work focuses on developing efficient methods for the manufacture of complex chemical compounds, which are crucial in the pharmaceutical industry.
Latest Patents
Mukherjee holds a patent for "Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one." This patent outlines highly efficient methods for preparing key intermediates in the synthesis of this compound, which can provide selected components with a variety of substituent groups.
Career Highlights
Throughout his career, Mukherjee has worked with prominent companies in the pharmaceutical sector, including Bristol-Myers Squibb Company and Janssen Pharmaceutica NV. His experience in these organizations has allowed him to refine his skills and contribute to innovative solutions in drug development.
Collaborations
Mukherjee has collaborated with talented professionals in his field, including Nicolas Cuniere and Yu Fan. These partnerships have enhanced his research and development efforts, leading to advancements in pharmaceutical synthesis.
Conclusion
Subha Mukherjee is a distinguished inventor whose work in pharmaceutical synthesis has made a lasting impact on the industry. His innovative approaches and collaborations continue to drive advancements in the field.